Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Abacavir Sulphate bulk supplier for pharma manufacturers

Abacavir Sulphate Suppliers & Bulk Manufacturers

Available Forms: Tablet and Oral Solution

Available Strengths: Tab: 300 mg; oral solution: 20 mg/ml

Reference Brands: Ziagen®, Triumeq®(EU & US); Epzicom®(US), Kivexa®*(EU)

Category: Anti Viral

Abacavir Sulphate Tablets 300 mg are essential antiretrovirals for HIV-1 treatment. PharmaB2B connects buyers with certified global suppliers offering high-quality bulk Abacavir. Available as tablets and oral solution, ideal for compliant, large-scale procurement from WHO-GMP or USFDA-approved manufacturers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Abacavir Sulphate Tablets are widely used in the treatment of HIV-1 infection, functioning as a nucleoside reverse transcriptase inhibitor (NRTI). Available in 300 mg tablets and pediatric oral solution (20 mg/mL), Abacavir is often combined with other antiretrovirals like Lamivudine and Dolutegravir. On PharmaB2B platforms, global buyers can connect with GMP-certified manufacturers and exporters offering high-quality Abacavir Sulphate for bulk supply. Ideal for procurement teams, distributors, and tender businesses seeking WHO-GMP or USFDA-approved sources, PharmaB2B simplifies compliant, cost-effective sourcing of essential antiretrovirals like Abacavir. Partner with trusted suppliers to support global access to HIV treatments.

Abacavir Sulphate — third party manufacturing & bulk supply

Abacavir Sulphate is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Abacavir Sulphate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Abacavir Sulphate →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Abacavir sulphate is used to treat HIV-1 infection. It helps reduce viral load and improve immune function by inhibiting the HIV reverse transcriptase enzyme, and is always used as part of combination antiretroviral therapy.

It is made from the active nucleoside reverse transcriptase inhibitor (NRTI) compound abacavir sulphate, a synthetic carbocyclic nucleoside analogue.

The commonly known trade name is Ziagen.

Ziagen is manufactured by GlaxoSmithKline (GSK) and ViiV Healthcare. Several global generic manufacturers also produce abacavir sulphate tablets.

The generic name is abacavir sulphate.

The primary brand name is Ziagen.

It is manufactured in approved facilities in the UK, USA, Europe, and India, depending on the innovator or generic company supplying the product.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.